Psychrobacter sanguinis has been described as a Gram-negative, aerobic coccobacilli originally isolated from environments and seaweed samples. To date, 6 cases of P. sanguinis infection have been reported. A 53-year-old male was admitted with a generalized tonic seizure lasting for 1 minute with loss of consciousness and a mild fever of 37.8 o C. A Gram stain revealed Gram-negative, small, and coccobacillishaped bacteria on blood culture. Automated microbiology analyzer identification using the BD BACTEC FX (BD Diagnostics, Germany) and VITEK2 (bioMérieux, France) systems indicated the presence of Methylobacterium spp., Aeromonas salmonicida, and the Moraxella group with low discrimination. The GenBank Basic Local Alignment Search Tool and an Ez-Taxon database search revealed that the 16S rRNA gene sequence of the isolate showed 99.30% and 99.88% homology to 859 base-pairs of the corresponding sequences of P. sanguinis, respectively (GenBank accession numbers JX501674.1 and HM212667.1). To the best of our knowledge, this is the first human case of P. sanguinis bacteremia in Korea. It is notable that we identified a case based on blood specimens that previously had been misidentified by a commercially automated identification analyzer. We utilized 16S rRNA gene sequencing as a secondary method for correctly identifying this microorganism. 
INTRODUCTION
Psychrobacter spp. are a Gram-negative, small, aerobic, non-motile, chemoheterotrophic, and halotolerant coccobacilli bacteria [1] . Psychrobacter spp. have been isolated from diverse habitats such as deep sea water, sea ice, marine sediments, and a wide range of food products including seafood and cheese [1] [2] [3] [4] . Psychrobacter isolates from humans are generally not clinically relevant. On occasion they have served as opportunistic pathogens in humans and have been isolated in clinical samples from brain tissue, urine, ears, wounds, cerebrospinal fluid (CSF), and blood. Most clinical isolates belong to the species P. immobilis and P. phenylpyruvicus [5] [6] [7] [8] [9] [10] .
In 2012, P. sanguinis was first described as a novel species based on four clinical specimens, and the type strain was isolated from the blood of an 84-year-old male in New York [11] .
Because P. sanguinis is a recently described species, data are lacking concerning its pathogenicity, and its clinical significance is not clear. Since the initial description of this microorganism, six cases of P. sanguinis infection have been reported in humans, specifically blood specimens and CSF [11] [12] [13] .
To the best our knowledge, this is the first report of a P. sanguinis bacteremia case identified by 16S rRNA gene sequencing in Korea.
CASE REPORT
A 53-year-old male was admitted to the emergency department after suffering one generalized tonic seizure for 1 minute with loss of consciousness. The patient had a 20-year history of We obtained a consensus sequence of 859 base-pairs (bp).
The sequence was analyzed using the GenBank Basic Local A phylogenetic tree based on the 16S rRNA sequences of the isolate and 20 organisms with similarity to the isolate was constructed using the neighbor-joining method (Fig. 3 ). Phylogenetic and molecular evolutionary analyses were conducted using Molecular Evolutionary Genetics Analysis (MEGA) software version 6.0 (http://www.megasoftware.net).
DISCUSSION
Psychrobacter sanguinis is a member of the Psychrobacter genus, which contains small, gram-negative, non-motile, chemoheterotrophic, and halotolerant coccobacilli bacteria [1] . The genus Psychrobacter contains 33 species with validly published names. Species of this genus have been observed from various origins, including the deep sea, water, sea ice, pigeon feces bioaerosols, and food products including seafood, poultry, and meat [1] [2] [3] [4] .
From 2004 to 2008, human blood cultures yielded four
Psychrobacter isolates at the Wadsworth Center in New York.
As the Wadsworth Center laboratory was not able to definitively identify them and the isolates did not provide an acceptable sequence similarity match to any species in the 16S rRNA sequence database, they were assigned to a single novel species.
This represented the first report of P. sanguinis in humans, and the type strain was isolated from the blood of an 84-year-old male in 2012 [11] . In 2014, P. sanguinis was isolated from the CSF of a 64-year-old female patient with post-neurosurgical meningitis, and this strain was identified only by 16S rRNA analysis [12] . In 2016, one case of meningitis associated with
Psychrobacter was reported, and this isolate was identified by next-generation sequencing (NGS) metagenomics in the CSF of a 13-year-old male patient. The closest relative of this strain was P. sanguinis on the basis of a DNA fingerprinting phylogenomic study and a 16S rRNA gene phylogenetic analysis [13] .
To date, a total of six cases of P. sanguinis human infection have been reported in the literature (Table 1) .
Current phenotypic identification systems, including the VITEK2 system, are unable to identify P. sanguinis and may confuse it with other organisms such as in this case, including
Methylobacterium spp., Aeromonas salmonicida, and the Moraxella group. The genus Psychrobacter currently belongs to the family Moraxellaceae [15] . In addition, M. phenylpyruvica has been reclassified to the genus Psychrobacter as P. phenylpyruvica, based on a sequence analysis of its 16S rRNA genes [16] . Published articles describing microorganisms misidentified by conventional methods are increasing [17] . It is evident that the number of newly-identified bacterial species is growing.
Consequently, the performance of commercially available biochemical platforms that allow an exact identification is decreasing, partly due to sequence database limitations. The unambiguous identification of unusual strains in clinical micro-biology is increasingly needed to improve our knowledge of tissue reservoirs, routes of transmission, antibiotic susceptibility, and enhancement of treatments, and to assist in the identification of novel bacterial species. Identification by conventional methods of rare bacteria and bacteria with unusual phenotypic profiles needs to be confirmed using a reliable tool such as 16S rRNA gene sequencing [18] .
In this case, 16S rRNA gene sequencing was required for accurate bacterial identification. Our study shows that sequencing of 16S rRNA and analyses using various databases are useful tools for the identification of unknown isolates. We report a first case in which P. sanguinis was isolated from human blood in Korea. In the six previously reported cases, we didn't detailed review for first reported case and the other three cases due to a lack of information in the literature [11] and two cases with meningitis were described as a probable infection [13] or a definite infection [12] . These cases were confirmed as a single organism with P. sanguinis infection by using molecular methods, and were treated with antibiotics. Only one patient [12] , antibiotic susceptibility testing was performed, which was susceptible to amoxicillin, ticarcillin, cefepime, ceftazidime, imipenem, meropenem, amikacin, ciprofloxacin, and trimethoprim-sulfamethoxazole. Therefore, amoxicillin treatment with 4g three times per day was continued until the patient had received 15 days of antimicrobial therapy. The patient experienced a rapid recovery under treatment with no other complications [12] .
Our study had several limitations. In our case, we attempted to identify the source of P. sanguinis, but it has proved difficult to ascertain how P. sanguinis caused bacteremia. It is likely that the bacteria were present in the patient's environment given that he had a mild fever on arrival at the emergency department, but this is less likely because blood cultures were drawn during hospitalization and sterile blood sampling. It is also possible that the patient had transient bacteremia due to his fever seemed to be improved with supportive care during admission day 2, but this is less likely because 37. Aerobic microbes are the most common cause of clinical infections such as community-acquired bacteremia and opportunistic infections, and aerobic bacteremia can be serious and even life-threatening in patients with weakened immune systems [19, 20] . Chronic heavy drinking increases the risk of infection by disrupting the immune system [21] [22] [23] . Although P. sanguinis is rarely reported as a pathogenic microorganism, it should be carefully considered in patients suffering from chronic alcoholism with fatty liver and nutritional imbalance. We isolated P.
sanguinis from blood and successfully identified it using molecular methods in clinical laboratories.
